Torrent Pharmaceuticals Limited has announced the cessation of Ameera Shah as an Independent Director, effective August 1, 2026. Ms. Shah completed her term as an Independent Director on this date. The company has provided the necessary details regarding this change in accordance with SEBI Listing Regulations, as outlined in Annexure A of their disclosure.
Director’s Term Concludes
Torrent Pharmaceuticals Limited has formally notified the cessation of Ameera Shah from her position as an Independent Director. This change became effective on August 1, 2026, as Ms. Shah’s term concluded. The company is fulfilling its disclosure obligations under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Disclosure Details
Further details pertaining to the cessation of Ms. Shah’s directorship are provided in Annexure A. This annexure includes information such as the reason for cessation, which is the completion of her term. The company has also confirmed that there are no other relationships between directors that are material to this change in directorship. The notification adheres to the requirements stipulated by SEBI Master Circulars.
Source: BSE
